Ligand Pharmaceuticals Inc (NASDAQ:LGND)

72.95
Delayed Data
As of Mar 27
 +2.65 / +3.77%
Today’s Change
41.99
Today|||52-Week Range
79.61
+37.10%
Year-to-Date

Today’s Trading

Previous close70.30
Today’s open70.52
Day’s range70.39 - 73.66
Volume253,009
Average volume (3 months)336,992
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+42.43%
Earnings growth (next 5 years)+38.40%
Revenue growth (last year)+31.78%
P/E ratio130.3
Price/Sales16.83
Price/Book54.26

Competitors

 Today’s
change
Today’s
% change
USNAUSANA Health Science...+4.02+3.74%
ACORAcorda Therapeutics ...+1.26+3.83%
NLNKNewLink Genetics Cor...+3.33+6.81%
CMRXChimerix Inc+0.50+1.37%
Data as of 4:02pm ET, 03/27/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)$0.27
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President, Chief Operating Officer &
Director
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account